SOAT1 and lung carcinoma: IDO was demonstrated to drive IL-6 production in lung cancer and metastatic breast cancer (Lox-Stop-Lox KrasG12D transgenic mice) [33], while IL-6 was confirmed to promote IDO expression via JAK/STAT signaling pathway [20].